EverPoint Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.29M | Buy |
110,000
+10,000
| +10% | +$208K | 0.04% | 276 |
|
|
2016
Q3 | $3.28M | Sell |
100,000
-250,000
| -71% | -$8.19M | 0.06% | 259 |
|
|
2016
Q2 | $8.74M | Sell |
350,000
-425,000
| -55% | -$10.6M | 0.17% | 132 |
|
|
2016
Q1 | $19M | Buy |
775,000
+175,000
| +29% | +$4.29M | 0.37% | 45 |
|
|
2015
Q4 | $19.8M | Buy |
600,000
+230,000
| +62% | +$7.6M | 0.42% | 48 |
|
|
2015
Q3 | $12.1M | Buy |
+370,000
| New | +$12.1M | 0.31% | 73 |
|
|
2015
Q1 | – | Sell |
-83,527
| Closed | -$2.43M | – | 575 |
|
|
2014
Q4 | $2.43M | Buy |
+83,527
| New | +$2.43M | 0.05% | 323 |
|